Found: 8
Select item for more details and to access through your institution.
Low dose of homoharringtonine and cytarabine combined with granulocyte colony-stimulating factor priming on the outcome of relapsed or refractory acute myeloid leukemia.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2011, v. 137, n. 6, p. 997, doi. 10.1007/s00432-010-0947-z
- By:
- Publication type:
- Article
基于培门冬酶的化疗用于治疗急性淋巴细胞白血病和T细胞淋巴瘤的临床疗效和安全性比较研究.
- Published in:
- Journal of Experimental Hematology / Zhongguo Shiyan Xueyexue Zazhi, 2016, v. 24, n. 2, p. 405, doi. 10.7534/j.issn.1009-2137.2016.02.018
- By:
- Publication type:
- Article
Short and Long Term Efficacy of Immunosuppressive Therapy and Survival in Adult Severe Aplastic Anemia.
- Published in:
- Journal of Experimental Hematology / Zhongguo Shiyan Xueyexue Zazhi, 2015, v. 23, n. 2, p. 471, doi. 10.7534/j.issn.1009-2137.2015.02.034
- By:
- Publication type:
- Article
Cohort Study on GHA and New Combined Priming Chemotherapeutic Regimens in Treatment of Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome.
- Published in:
- Journal of Experimental Hematology / Zhongguo Shiyan Xueyexue Zazhi, 2015, v. 23, n. 2, p. 369, doi. 10.7534/j.issn.1009-2137.2015.02.014
- By:
- Publication type:
- Article
Construction and Significance of Directional Expression cDNA Library from Myeloid Leukemia Cell Line U937.
- Published in:
- Journal of Experimental Hematology / Zhongguo Shiyan Xueyexue Zazhi, 2003, v. 11, n. 4, p. 355
- By:
- Publication type:
- Article
Role of IL-17A rs2275913 and IL-17F rs763780 polymorphisms in risk of cancer development: an updated meta-analysis.
- Published in:
- Scientific Reports, 2016, p. 20439, doi. 10.1038/srep20439
- By:
- Publication type:
- Article
Five-year remission without disease progression in a patient with relapsed/refractory multiple myeloma with extramedullary disease treated with LCAR-B38M chimeric antigen receptor T cells in the LEGEND-2 study: a case report.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2).
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01301-8
- By:
- Publication type:
- Article